Dr. Harold L. Manning, MD

Dr. Manning practices at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health.

Dr. Manning's NPI, 1578579538, was assigned on July 31, 2006. Dr. Manning graduated from Johns Hopkins University School of Medicine in 1982. Dr. Manning holds New Hampshire license 8355.

Dr. Manning's primary practice is Dartmouth Hitchcock Medical Center, at 1 Medical Center Drive, Lebanon, NH 03756 in Grafton County. The practice phone is (603) 650-5000.

Dr. Manning's primary practice is Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health. Dr. Manning is also affiliated with Alice Peck Day Memorial Hospital. The medical group on file is Dartmouth Hitchcock Medical Center. Dmand AI also links Dr. Manning to 3 more hospitals and 1 medical group, each named with a free account. Dr. Manning's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Manning practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Manning's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Manning is licensed in New Hampshire.

CMS data shows 787 Medicare services from Dr. Manning across 12 procedure codes in 2024, for 404 Medicare patients. Medicare paid $46,520 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 404 Medicare patients who saw Dr. Manning in 2024. The largest group is 75 to 84, with 163 patients. 74% of them have high blood pressure, and 66% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Manning's median patient age at 65, with 56% women.

In 2024, Dr. Manning wrote 396 Medicare Part D claims for 92 patients. 42% of them were for generic drugs. CMS names the drug for 307 of them, across 11 drugs with 11 or more claims each, at $152,379 in total drug cost. In 2023, CMS named 314 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Manning for performance year 2024, reported through an alternative payment model (APM). Dr. Manning accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 14 papers to Dr. Manning, published from 2012 to 2025. 2019 was the busiest year, with 2. The most frequent topics are Lung, Neoplastic Cells, Circulating and Palliative Care. Dr. Manning has published most often in Ann Am Thorac Soc. Dr. Manning's most frequent co-authors are Clay A. Block, MD, Brian David Remillard, MD and Joshua O. Benditt.

CMS Open Payments shows 1 general payment to Dr. Manning from 1 drug or device company in 2023. Education make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $67.

Dr. Manning graduated from Johns Hopkins University School of Medicine in 1982.